Literature DB >> 12759239

Protease-activated receptor-2 signaling triggers dendritic cell development.

Ryan C Fields1, Jonathan G Schoenecker, Justin P Hart, Maureane R Hoffman, Salvatore V Pizzo, Jeffrey H Lawson.   

Abstract

Dendritic cells (DC) are potent antigen-presenting cells that govern the effector cell responses of the immune system. DC are thought to continuously develop from circulating progenitors in a process that is accelerated by inflammatory stimuli. However, the physiological signals that regulate the development of DC from precursor cells have not been well defined. Here we show that a serine protease acting via protease-activated receptor-2 (PAR-2) stimulates the development of DC from bone marrow progenitor cells cultured in granulocyte-macrophage colony-stimulating factor and IL-4. DC fail to develop in bone marrow cultures treated with soy bean trypsin inhibitor, a serine protease inhibitor, but this inhibition is overcome by a PAR-2 agonist peptide. DC do not spontaneously develop from the bone marrow of PAR-2-deficient mice, but can be stimulated to do so by inflammatory mediators. These results suggest that endogenous serine proteases stimulate DC development in vitro. Thus, serine proteases may help trigger adaptive immune responses in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12759239      PMCID: PMC1868121          DOI: 10.1016/S0002-9440(10)64316-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

Review 1.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Natural adjuvants: endogenous activators of dendritic cells.

Authors:  S Gallucci; M Lolkema; P Matzinger
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

3.  Extracellular antigen processing and presentation by immature dendritic cells.

Authors:  L Santambrogio; A K Sato; G J Carven; S L Belyanskaya; J L Strominger; L J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

4.  A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

Authors:  J P Ridge; F Di Rosa; P Matzinger
Journal:  Nature       Date:  1998-06-04       Impact factor: 49.962

5.  Apoptosis. Phagocytic docking without shocking.

Authors:  J Savill
Journal:  Nature       Date:  1998-04-02       Impact factor: 49.962

Review 6.  Dendritic cell development and maturation.

Authors:  R M Steinman; M Pack; K Inaba
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

Review 7.  Apoptosis or necrosis for tumor immunotherapy: what's in a name?

Authors:  A Melcher; M Gough; S Todryk; R Vile
Journal:  J Mol Med (Berl)       Date:  1999-12       Impact factor: 4.599

8.  Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.

Authors:  E Camerer; W Huang; S R Coughlin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

9.  Proteinase-activated receptor-2-activating peptides induce leukocyte rolling, adhesion, and extravasation in vivo.

Authors:  N Vergnolle
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

10.  Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo.

Authors:  R C Fields; K Shimizu; J J Mulé
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

View more
  24 in total

1.  Bovine thrombin and systemic autoimmunity.

Authors:  Bruce N Cronstein
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

2.  PAR(2) expression in peripheral blood monocytes of patients with rheumatoid arthritis.

Authors:  A Crilly; E Burns; M B Nickdel; J C Lockhart; M E Perry; P W Ferrell; D Baxter; J Dale; L Dunning; H Wilson; J S Nijjar; J A Gracie; W R Ferrell; I B McInnes
Journal:  Ann Rheum Dis       Date:  2012-01-30       Impact factor: 19.103

Review 3.  Protease-activated receptor 2 signaling in inflammation.

Authors:  Andrea S Rothmeier; Wolfram Ruf
Journal:  Semin Immunopathol       Date:  2011-10-06       Impact factor: 9.623

Review 4.  Role of cockroach proteases in allergic disease.

Authors:  Kristen Page
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

Review 5.  Mast cell plasticity and sphingosine-1-phosphate in immunity, inflammation and cancer.

Authors:  Carole A Oskeritzian
Journal:  Mol Immunol       Date:  2014-04-22       Impact factor: 4.407

6.  TLR4-mediated immunomodulatory properties of the bacterial metalloprotease arazyme in preclinical tumor models.

Authors:  Felipe V Pereira; Amanda C L Melo; Filipe M de Melo; Diego Mourão-Sá; Priscila Silva; Rodrigo Berzaghi; Carolina C A Herbozo; Jordana Coelho-Dos-Reis; Jorge A Scutti; Clarice S T Origassa; Rosana M Pereira; Luis Juliano; Maria Aparecida Juliano; Adriana K Carmona; Niels O S Câmara; Moriya Tsuji; Luiz R Travassos; Elaine G Rodrigues
Journal:  Oncoimmunology       Date:  2016-05-05       Impact factor: 8.110

7.  Initial support for the hypothesis that PAR2 is involved in the immune response to Nippostrongylus brasiliensis in mice.

Authors:  Mark G Devlin; Robin B Gasser; Tom M Cocks
Journal:  Parasitol Res       Date:  2007-02-14       Impact factor: 2.289

Review 8.  Protease-activated receptors and prostaglandins in inflammatory lung disease.

Authors:  Terence Peters; Peter J Henry
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

9.  Protease-activated receptor 2 signalling promotes dendritic cell antigen transport and T-cell activation in vivo.

Authors:  Giancarlo Ramelli; Silvia Fuertes; Sharmal Narayan; Nathalie Busso; Hans Acha-Orbea; Alexander So
Journal:  Immunology       Date:  2009-06-22       Impact factor: 7.397

10.  Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome.

Authors:  Anaïs Briot; Céline Deraison; Matthieu Lacroix; Chrystelle Bonnart; Aurélie Robin; Céline Besson; Pierre Dubus; Alain Hovnanian
Journal:  J Exp Med       Date:  2009-05-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.